Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01027715 · ClinicalTrials.gov registry record · NA
The Impact of Electroencephalographic (EEG) Seizure Treatment in Neonatal Encephalopathy
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT01027715 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 69 participants.
The verdict
NCT01027715, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
This is a prospective, randomized, single-center pilot trial of term and near term (≥ 36 weeks gestation) infants with encephalopathy or seizures comparing a "EEG Seizure Treatment Group" or ESG with a "Clinical Seizure Treatment Group" or CSG. The investigators hypothesize that the accurate detection and treatment of EEG seizures will decrease the seizure burden and improve outcomes in newborn infants with seizures and/or hypoxic-ischemic encephalopathy (HIE).
Interventions
- OTHER EEG monitoring and treatment of EEG seizures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2010-01 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01027715
The ClinicalTrials.gov registry entry for NCT01027715 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EEG monitoring and treatment of EEG seizures is the first listed.
NCT01027715 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01027715 about?
NCT01027715 is a clinical study titled "The Impact of Electroencephalographic (EEG) Seizure Treatment in Neonatal Encephalopathy". This is a prospective, randomized, single-center pilot trial of term and near term (≥ 36 weeks gestation) infants with encephalopathy or seizures comparing a "EEG Seizure Treatment Group" or ESG with a "Clinical Seizure Treatment Group" or CSG. The investigators hypothesize that the accurate detect...
What is the current status of trial NCT01027715?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2010-01. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01027715?
The interventions under investigation include: EEG monitoring and treatment of EEG seizures (OTHER).
Who is sponsoring clinical trial NCT01027715?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.